Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study

INTRODUCTION: Secukinumab has demonstrated sustained long-term efficacy with a favourable safety profile in various manifestations of psoriatic disease. We investigated effectiveness and safety of secukinumab, other biologics and conventional systemic therapies in patients with chronic plaque psoria...

Descripción completa

Detalles Bibliográficos
Autores principales: Foley, Peter, Tsai, Tsen-Fang, Rodins, Karl, Hamadah, Issam Ribhi, Ammoury, Alfred, Dayem, Hussein Abdel, Abdallah, Mahmoud, Crowe, Susanne, Haas, Silvia, Pournara, Effie, Jagiello, Piotr, Huang, Yu-Huei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850524/
https://www.ncbi.nlm.nih.gov/pubmed/35038128
http://dx.doi.org/10.1007/s13555-021-00675-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850524/
https://www.ncbi.nlm.nih.gov/pubmed/35038128
http://dx.doi.org/10.1007/s13555-021-00675-w

Ejemplares similares